Skip to content
Review Open access

Mapping the Epigenetic Regulatory Landscape and Core Transcriptional Axes Across Cell Cycle Phases in Lung Cancer

Nov 2026 · International Journal of Molecular Sciences · Vol 27 · 0 citations · 105 references
Medicine

Abstract

Lung-cancer cell-cycle progression is shaped by interacting checkpoint, transcriptional, chromatin, and non-coding RNA regulatory layers rather than by isolated molecular alterations. This integrative review uses SMARCB1, NOC2L, CDCA4, and CHEK1 as four complementary anchor regulators representing SWI/SNF-dependent chromatin remodeling, inhibition of histone acetyltransferase activity, E2F-linked transcriptional modulation, and checkpoint signaling, respectively. We critically map their literature-supported relationships across G1, S, G2, and M and integrate DNA and histone methylation, acetylation, chromatin remodeling, phosphorylation, ubiquitination, hydroxylation, and non-coding RNA regulation. Importantly, lung-cancer-specific evidence is distinguished from evidence extrapolated from other tumor models, and experimentally established mechanisms are separated from contextual or hypothesis-generating phase assignments. The strongest lung-specific evidence concerns CHEK1 dependence, replication stress, and chromatin-state plasticity, whereas several proposed phase-specific functions of NOC2L, CDCA4, and SMARCB1 remain incompletely validated in lung cancer. Recent 2026 studies further emphasize subtype-specific CHEK1 biology, therapy-associated chromatin reprogramming, and long non-coding RNA control. This framework identifies testable regulatory hypotheses while avoiding interpretation of network association as direct causality.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.